Epigenetic modifiers either individually or in specific combinations impair viability of patient-derived glioblastoma cell line while exhibit moderate effect on normal stem cells growth
Year: 2023
Type: article
Source: Investigational New Drugs
Institutions: Mayo Clinic, Mayo Clinic in Florida
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: green
Funder: National Institutes of Health
OpenAlex ID: W4376121311
